Belantamab mafodotin 1.0 mg/kg (12 weeks) Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Nashville, Tennessee1 trial

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Vanderbilt Ingram Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.